Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Depressed mood, Fatigue, Myalgia, Underdose, Vaccination site discharge
Clinical narrative: Injection site is red; Injection site is swollen; Injection site is sore; Fatigue; Muscle aches around waist; Feeling down; Patient noticed 2 drops leaking from the injection site,after receiving the vaccine; Recieved 0.25mL but is unsure if it was 0.25ml; This spontaneous case was reported by a patient and describes the occurrence of DEPRESSED MOOD (Feeling down), VACCINATION SITE DISCHARGE (Patient noticed 2 drops leaking from the injection site,after receiving the vaccine), UNDERDOSE (Recieved 0.25mL but is unsure if it was 0.25ml), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE SWELLING (Injection site is swollen) in a 30-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-May-2021, the patient received first dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 19-Jun-2021, received second dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. On 16-Dec-2021, received third dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to 1 dosage form. On 07-Sep-2022, received fourth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .25 milliliter. On 07-Sep-2022, the patient experienced UNDERDOSE (Recieved 0.25mL but is unsure if it was 0.25ml). On an unknown date, the patient experienced DEPRESSED MOOD (Feeling down), VACCINATION SITE DISCHARGE (Patient noticed 2 drops leaking from the injection site,after receiving the vaccine), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen), VACCINATION SITE PAIN (Injection site is sore), FATIGUE (Fatigue) and MYALGIA (Muscle aches around waist). At the time of the report, DEPRESSED MOOD (Feeling down), VACCINATION SITE DISCHARGE (Patient noticed 2 drops leaking from the injection site,after receiving the vaccine), UNDERDOSE (Recieved 0.25mL but is unsure if it was 0.25ml), VACCINATION SITE ERYTHEMA (Injection site is red), VACCINATION SITE SWELLING (Injection site is swollen), VACCINATION SITE PAIN (Injection site is sore), FATIGUE (Fatigue) and MYALGIA (Muscle aches around waist) outcome was unknown.            Patient had no allergies. No concomitant medications were reported. Patient never had COVID positive test or diagnosis. Patient Received Bivalent on 07-Sep-2022, she received 0.25mL stated that it was the standard dose for all boosters, believed that was what it stated in the news, but it was unsure if it was 0.25ml. After receiving the vaccine, she noticed after noticed 2 drops leaking from the injection site, and wanted to know if she was under dosed, did she had full protection or adequate antibodies.  No treatment information was provided.